Expression of CircRNAs in HIV infection and latency

HIV感染和潜伏期中CircRNA的表达

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Circular RNAs (circRNAs) are single stranded covalently closed RNAs, which lack the classical characteristics of linear mRNA such as 5’ cap and 3’ poly-A tails. CircRNAs expression patterns are sensitive to viral infection and cell division rates, which allows us to propose the hypothesis that circRNAs might be involved in infection and latency state of HIV-1. HIV-1 is still one of the world’s most significant infectious diseases and, despite the vast attempts, its cure has not been found. Most of the transcriptomic studies in HIV-1 have been focused on RNA species, like messengers RNAs or micro RNA but the expression of circRNAs during early and late stages of infections in addition to their response to antiretroviral therapy (ART) remains unknown. Furthermore, the major barrier impeding HIV-1 eradication is a small reservoir of latently infected resting T-cells that persist after ART and can spawn new waves of infection. CircRNAs could serve as biomarkers for latent HIV-1 cells or could be important in processes of HIV-1 reactivation, for the kick and kill or block and lock HIV-1 eradication strategy. Here we will identify circRNAs implicated in early and late stages of HIV-1 infection in addition to the role of circRNAs involved in latency. Additionally, the effect of several ARTs and latency reversal agents on the expression of circRNAs will be explored. As preliminary results, we have analyzed data from two different time points during HIV-1 infection and from an in vitro HIV-1 latency model. The results on the time after HIV-1 infection showed differences of circRNA expression through time. On the other hand, the results of the in vitro HIV-1 latency model showed a significant downregulation of circRNAs after latency reactivation, and two circRNAs as potential biomarkers of HIV-1 latent cell. Results will increase the knowledge on HIV-1 viral infection and innate immune response to it. Additionally, circRNAs might point to the identification of novel cellular RNAs targets for discovery or design interventions that control HIV-1 infection and latency.
项目总结/摘要 环状RNA(Circular RNA,circRNA)是一类单链共价闭合的RNA,缺乏经典的特征 如5'帽和3'聚腺苷酸尾。CircRNA表达模式对病毒感染敏感 和细胞分裂率,这使我们能够提出circRNA可能参与感染的假设 和HIV-1的潜伏状态。HIV-1仍然是世界上最重要的传染病之一,尽管 尽管进行了大量的尝试,但尚未找到治愈方法。大多数HIV-1的转录组学研究都集中在 RNA种类,如信使RNA或微RNA,但在早期和晚期表达circRNA 除了抗逆转录病毒治疗(ART)的反应外,感染的风险仍然未知。而且 阻碍HIV-1根除的主要障碍是一小部分潜伏感染的静息T细胞, 抗逆转录病毒疗法,并可能产生新的感染浪潮。CircRNA可以作为潜伏的HIV-1细胞的生物标志物, 在HIV-1重新激活的过程中,对于踢和杀死或阻止和锁定HIV-1根除战略至关重要。 在这里,我们将鉴定出与HIV-1感染早期和晚期有关的circRNA, circRNA参与潜伏期。此外,几种ART和潜伏期逆转剂对 将探索circRNA的表达。作为初步结果,我们分析了两个不同时间的数据, 点在HIV-1感染和从体外HIV-1潜伏期模型。HIV-1感染后的时间 感染显示circRNA表达随时间的差异。另一方面,体外实验的结果表明, HIV-1潜伏期模型显示,在潜伏期再激活后,circRNA显著下调, circRNA作为HIV-1潜伏细胞的潜在生物标志物。结果将增加对HIV-1病毒感染的认识 此外,circRNA可能指向新的细胞RNA的鉴定, 发现或设计控制HIV-1感染和潜伏期的干预措施的目标。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression.
  • DOI:
    10.3390/v14071571
  • 发表时间:
    2022-07-20
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Miguel De Mulder Rougvie其他文献

Miguel De Mulder Rougvie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Miguel De Mulder Rougvie', 18)}}的其他基金

Expression of CircRNAs in HIV infection and latency
HIV感染和潜伏期中CircRNA的表达
  • 批准号:
    10013870
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 21.19万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 21.19万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了